HCM
MRNA icon

Hitchwood Capital Management’s Moderna MRNA Stock Holding History

Hitchwood Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-350,000
Closed -$5.12M – 53
2019
Q2 		$5.12M Hold
350,000
– – 0.09% 54
2019
Q1 		$7.12M Buy
+350,000
New +$6.5M 0.1% 50

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
RWA
Ropes Wealth Advisors Boston, Massachusetts $515M AUM 21.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hitchwood Capital Management's MRNA Position: Q3 2019 in Review

Hitchwood Capital Management sold out of Moderna (MRNA) in Q3 2019, closing a stake of 350,000 shares — an estimated $5.12M sold.

Hitchwood Capital Management first reported a position in MRNA in Q1 2019 and held it in 2 quarters. The position peaked at $7.12M in Q1 2019. 136 funds tracked by Wall St. Rank hold MRNA as of Q3 2019.

  • Hitchwood Capital Management reported no remaining Moderna position as of Q3 2019 after selling out during the quarter.
  • Hitchwood Capital Management sold 350,000 Moderna shares in Q3 2019, an estimated $5.12M.
  • Hitchwood Capital Management first reported a position in Moderna in Q1 2019 and held it in 2 quarters.
  • Hitchwood Capital Management's Moderna position peaked at $7.12M in Q1 2019.
  • 136 funds tracked by Wall St. Rank held Moderna as of Q3 2019.

Based on Hitchwood Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.